PPSS expresses tumor markers such as transducin-like enhancer of split-1 (TLE1) and B-cell lymphoma 2 (Bcl-2), which can differentiate PPSS from other sarcomas, highlighting the importance of immunohistochemical (IHC) investigations as an important tool to rule out other sarcomas. The gene discussed is BCL2; the disease is sarcoma.